SCHEMBL2648445

SCHEMBL2648445

CCCOC1CCC(N(C(=O)Nc2ncc(S(=O)(=O)N3CCCC3C(=O)O)s2)C2CCCCC2)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.39
MMP8 P22894 1/20 0.38
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
ALDH1A1 P00352 5/20 0.37
KCNQ1 P51787 1/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PDE5A O76074 2/20 0.36
PDE6D O43924 1/20 0.36
PDE6A P16499 1/20 0.36
PDE6G P18545 1/20 0.36
PDE6B P35913 1/20 0.36
PDE6C P51160 1/20 0.36
PDE6H Q13956 1/20 0.36
KMT2A Q03164 1/20 0.35
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2648442 1.00 POLB (0.39) POLBMMP8MMP12MMP13ALDH1A1
SCHEMBL2648444 1.00 POLB (0.39) POLBMMP8MMP12MMP13ALDH1A1
SCHEMBL2650763 0.88 POLB (0.47) POLBMMP8MMP12MMP13ALDH1A1
SCHEMBL2650760 0.88 POLB (0.47) POLBMMP8MMP12MMP13ALDH1A1
SCHEMBL2648990 0.87 POLB (0.44) POLBMMP8MMP12MMP13ALDH1A1
SCHEMBL2648534 0.87 POLB (0.44) POLBMMP8MMP12MMP13ALDH1A1
SCHEMBL2648532 0.87 POLB (0.44) POLBMMP8MMP12MMP13ALDH1A1
SCHEMBL2648538 0.87 POLB (0.44) POLBMMP8MMP12MMP13ALDH1A1
SCHEMBL2648989 0.87 POLB (0.44) POLBMMP8MMP12MMP13ALDH1A1
SCHEMBL30378260 0.83 MAPT (0.37) ALDH1A1MAPTMAPK1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582769-B2 Dicycloalkyl urea glucokinase activators NOVO NORDISK A/S (DK) 2009-09-01 US disclosed
US-20090118501-A1 Dicycloalkyl Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2009-05-07 US disclosed
EP-1904466-A1 DICYCLOALKYL UREA GLUCOKINASE ACTIVATORS Novo Nordisk A/S (DK) 2008-04-02 EP disclosed
WO-2007006760-A1 DICYCLOALKYL UREA GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118501-A1 Dicycloalkyl Urea Glucokinase Activators GCK, GCKR, UCK2 POLB 3011/4885MMP8 1685/4885MMP12 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.